The tumor was stable radiographically without enhancement and had stable 2HG measurements on 11 MRS exams over 3.3 years (3.8–5.0 mM), consistent with the presumptive diagnosis of an IDH‐mutant low‐grade glioma. The gene discussed is IDH1; the disease is central nervous system cancer.